Smad3 and Smad3 phosphoisoforms are prognostic markers of gastric carcinoma.

scientific article published on 18 November 2012

Smad3 and Smad3 phosphoisoforms are prognostic markers of gastric carcinoma. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10620-012-2470-3
P698PubMed publication ID23179147

P50authorJiyeon HyeonQ46810839
P2093author name stringKyung-Hee Kim
Seok-Hyung Kim
Cheol-Keun Park
Soomin Ahn
P2860cites workSmad-dependent and Smad-independent pathways in TGF-beta family signallingQ28208250
Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factorsQ28282622
TGFbeta in CancerQ28288866
Reversible Smad-dependent signaling between tumor suppression and oncogenesisQ28564212
Decreased levels of active SMAD2 correlate with poor prognosis in gastric cancerQ31060222
Phosphorylated Smad2 in Advanced Stage Gastric CarcinomaQ33756656
How the Smads regulate transcriptionQ37025325
Transforming growth factor-{beta}-inducible phosphorylation of Smad3Q39883712
A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinomaQ39986296
Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathwayQ40028490
Prognostic significance of the expression of Smad4 and Smad7 in human gastric carcinomasQ44434503
Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.Q45386179
Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinomaQ45402508
Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor- suppression in rat hepatocellular carcinoma.Q46024086
Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer.Q53373344
Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.Q53389037
Acceleration of Smad2 and Smad3 phosphorylation via c-Jun NH(2)-terminal kinase during human colorectal carcinogenesis.Q54684094
P433issue4
P304page(s)989-997
P577publication date2012-11-18
P1433published inDigestive Diseases and SciencesQ15716711
P1476titleSmad3 and Smad3 phosphoisoforms are prognostic markers of gastric carcinoma
P478volume58

Reverse relations

cites work (P2860)
Q48134448A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells
Q38790780Deregulated E2F5/p38/SMAD3 Circuitry Reinforces the Pro-Tumorigenic Switch of TGFβ Signaling in Prostate Cancer
Q90092784Knockdown of SMAD3 inhibits the growth and enhances the radiosensitivity of lung adenocarcinoma via p21 in vitro and in vivo
Q37586829Negative immune factors might predominate local tumor immune status and promote carcinogenesis in cervical carcinoma
Q51741868The Effects of Smad3 on Adrenocorticotropic Hormone-Secreting Pituitary Adenoma Development, Cell Proliferation, Apoptosis, and Hormone Secretion.
Q39121230The prognostic significance of Smad3, Smad4, Smad3 phosphoisoform expression in esophageal squamous cell carcinoma

Search more.